Thought Leadership & Innovation Foundation to Launch Autism Knowledge Gateway at “An Evening to Advance Autism Care” Event
October 22, 2024 10:00 ET
|
Thought Leadership & Innovation Foundation
Autism Knowledge Gateway Launch at “An Evening to Advance Autism Care”
Thought Leadership & Innovation Foundation Announces Gala to Initiate Development of Patient Portal for Age-Related Macular Degeneration
September 16, 2024 10:00 ET
|
Thought Leadership & Innovation Foundation
Thought Leadership & Innovation Foundation, American Macular Degeneration Foundation Announce Gala Event to Support AMD Patient Portal Development
Key Highlights of Lighthouse Fusion
August 27, 2024 09:00 ET
|
Lighthouse Autism Center
Lighthouse Autism Center expands its speech therapy program with more dually certified SLPs and BCBAs, offering better outcomes for children with autism.
Lighthouse Autism Center Partners with Local Government Officials to Highlight Autism Services and Community Impact
August 16, 2024 09:00 ET
|
Lighthouse Autism Center
Lighthouse Autism Center partners with local officials to boost autism awareness and support, with visits in several cities to highlight services.
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
May 15, 2024 08:30 ET
|
PaxMedica, Inc.
TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) (OTC:PXMD), a biopharmaceutical company dedicated to advancing treatments for...
NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
May 09, 2024 09:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX Accelerator Program. KidsX is a global leader in pediatric digital...
Catalight Practice Guidelines Reflect a Contemporary Research View of the Dosage Effect and Outcome Measures in Autism Care
April 23, 2024 17:28 ET
|
Catalight
WALNUT CREEK, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Catalight, one of the largest behavioral health networks in the United States working to support individuals with autism and intellectual and...
SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments
January 04, 2024 07:18 ET
|
SciSparc Ltd
The collaboration included six different provisional patent applications filed by Clearmind with the United States Patent and Trademark Office in February 2023 to protect the novel combinations of...
NeuroQure Acquires Patents to Detect Autism in Newborns with a Skin Sample
December 13, 2023 09:30 ET
|
NeuroQure
IRVINE, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- NeuroQure, a pioneering biotech startup specializing in gene therapy for neurocognitive disorders, has reached a pivotal milestone in the...
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
December 13, 2023 08:18 ET
|
SciSparc Ltd
MitoCareX Bio met its second milestone as part of its joint venture agreement with the Company TEL AVIV, Israel, Dec. 13, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...